Related references
Note: Only part of the references are listed.New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment
Francisco Cervantes et al.
BLOOD (2009)
The role of cytogenetic abnormalities as a prognostic marker in primary myelofibrosis: applicability at the time of diagnosis and later during disease course
Constantine S. Tam et al.
BLOOD (2009)
The natural history and treatment outcome of blast phase BCR-ABL(-) myeloproliferative neoplasms
Constantine S. Tam et al.
BLOOD (2008)
Risk factors for leukemic transformation in patients with primary myelofibrosis
Jocelin Huang et al.
CANCER (2008)
Monocytosis is an adverse prognostic factor for survival in younger patients with primary myelofibrosis
M. A. Elliott et al.
LEUKEMIA RESEARCH (2007)
Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia: Results from the US Intergroup Phase III Trial E2997
Michael R. Grever et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Polycythemia vera is not initiated by JAK2(V17F) mutation
Roberto H. Nussenzveig et al.
EXPERIMENTAL HEMATOLOGY (2007)
Hematopoietic cell transplantation as curative therapy for idiopathic myelofibrosis, advanced polycythemia vera, and essential thrombocythemia
Daniella M. B. Kerbauy et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2007)
Allogeneic hematopoietic stern-cell transplantation with reduced-intensity conditioning in intermediate- or high-risk patients with myelofibrosis with myeloid metaplasia
D Rondelli et al.
BLOOD (2005)
Accelerated and blastic phases of chronic myelogenous leukemia
FJ Giles et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2004)
Cytogenetic findings and their clinical relevance in myelofibrosis with myeloid metaplasia
A Tefferi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Genomic aberrations and survival in chronic lymphocytic leukemia.
H Döhner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
